Literature DB >> 16645139

Motor cortex activation during treatment may predict therapeutic gains in paretic hand function after stroke.

Yun Dong1, Bruce H Dobkin, Steven Y Cen, Allan D Wu, Carolee J Winstein.   

Abstract

BACKGROUND AND
PURPOSE: Functional brain imaging after stroke offers insight into motor network adaptations. This exploratory study examined whether motor cortical activation captured during arm-focused therapy can predict paretic hand functional gains.
METHODS: Eight hemiparetic patients had serial functional MRI (fMRI) while performing a pinch task before, midway, and after 2 weeks of constraint-induced therapy. The Wolf Motor Function Test (WMFT) was performed before and after intervention.
RESULTS: There was a linear reduction in ipsilateral (contralesional) primary motor (M1) activation (voxel counts) across time. The midpoint M1 Laterality Index anticipated post-therapeutic change in time to perform the WMFT. The change in ipsilateral M1 voxel count (pre- to mid-) correlated with the change in mean WMFT time (pre- to post-).
CONCLUSIONS: The relationship between brain activation during treatment and functional gains suggests a use for serial fMRI in predicting the success and optimal duration for a focused therapeutic intervention.

Entities:  

Mesh:

Year:  2006        PMID: 16645139     DOI: 10.1161/01.STR.0000221281.69373.4e

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  50 in total

1.  The EXCITE Trial: analysis of "noncompleted" Wolf Motor Function Test items.

Authors:  Steven L Wolf; Paul A Thompson; Emily Estes; Timothy Lonergan; Rozina Merchant; Natasha Richardson
Journal:  Neurorehabil Neural Repair       Date:  2011-11-09       Impact factor: 3.919

2.  Implicit sequence-specific motor learning after subcortical stroke is associated with increased prefrontal brain activations: an fMRI study.

Authors:  Sean K Meehan; Bubblepreet Randhawa; Brenda Wessel; Lara A Boyd
Journal:  Hum Brain Mapp       Date:  2011-02       Impact factor: 5.038

Review 3.  Confounders in rehabilitation trials of task-oriented training: lessons from the designs of the EXCITE and SCILT multicenter trials.

Authors:  Bruce H Dobkin
Journal:  Neurorehabil Neural Repair       Date:  2007 Jan-Feb       Impact factor: 3.919

Review 4.  Brain-computer interface technology as a tool to augment plasticity and outcomes for neurological rehabilitation.

Authors:  Bruce H Dobkin
Journal:  J Physiol       Date:  2006-11-09       Impact factor: 5.182

5.  Evolution of FMRI activation in the perilesional primary motor cortex and cerebellum with rehabilitation training-related motor gains after stroke: a pilot study.

Authors:  Yun Dong; Carolee J Winstein; Richard Albistegui-DuBois; Bruce H Dobkin
Journal:  Neurorehabil Neural Repair       Date:  2007-03-16       Impact factor: 3.919

6.  Greater activation of secondary motor areas is related to less arm use after stroke.

Authors:  Kristen J Kokotilo; Janice J Eng; Martin J McKeown; Lara A Boyd
Journal:  Neurorehabil Neural Repair       Date:  2009-09-08       Impact factor: 3.919

Review 7.  Experience, cortical remapping, and recovery in brain disease.

Authors:  George F Wittenberg
Journal:  Neurobiol Dis       Date:  2009-09-19       Impact factor: 5.996

Review 8.  Biomarkers of recovery after stroke.

Authors:  Marie-Hélène Milot; Steven C Cramer
Journal:  Curr Opin Neurol       Date:  2008-12       Impact factor: 5.710

9.  Effects of socioeconomic status on brain development, and how cognitive neuroscience may contribute to levelling the playing field.

Authors:  Rajeev D S Raizada; Mark M Kishiyama
Journal:  Front Hum Neurosci       Date:  2010-02-05       Impact factor: 3.169

10.  Comparing unilateral and bilateral upper limb training: the ULTRA-stroke program design.

Authors:  A Lex E Q van Delden; C Lieke E Peper; Jaap Harlaar; Andreas Daffertshofer; Nienke I Zijp; Kirsten Nienhuys; Peter Koppe; Gert Kwakkel; Peter J Beek
Journal:  BMC Neurol       Date:  2009-11-06       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.